Skip to main content
SpringerLink
Log in

Locoregional Melanoma Therapy by Tissue Adhesive Microneedle Patch-assisted Trans-tumoral Delivery of Anticancer Drug

  • Research Paper
  • Published:
Biotechnology and Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Melanoma is one of the most threatening cancers due to its metastatic capacity and its incidence is recently increasing due to ozone depletion and excessive exposure to ultraviolet. Adjuvant therapy after primary surgical resection is commonly used to prevent tumor recurrence. However, its clinical outcome is not often satisfactory, mainly due to insufficient local accumulation and the systemic toxicity of antitumor drugs. Herein, we reported a self-biodegradable tissue adhesive microneedle (MN) patch for localized and sustained delivery of doxorubicin (DOX) via microchannels for melanoma growth inhibition. DOX-loaded MN patches were fabricated by casting bioengineered mussel adhesive protein (MAP) solution containing DOX onto poly (dimethyl siloxane) molds with MN-shaped cavities under backside vacuum. The fabricated MAP-based MN patch enabled effective tissue insertion for fresh and living mice skins as well as firm surface adhesion. Notably, DOX-laden MN (DOX-MN) patch significantly suppressed B16F10 melanoma cell proliferation in vitro, while drug-free MN patch did not show any cytotoxicity for both NIH3T3 fibroblasts and B16F10 melanoma cells. In a melanoma-bearing mice model, DOX-MN patch treatment induced greater antitumor efficacy as demonstrated by significant decrease in tumor volume and weight and larger necrotic region compared with intratumoral injection of free DOX. We expect that this strategy can also integrate with other immunomodulators to provide further combinative therapy for effectively eradicating tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data Availability

The raw data required to reproduce these findings will be made available upon request.

References

  1. Parker, E. R. (2021) The influence of climate change on skin cancer incidence — a review of the evidence. Int. J. Womens Dermatol. 7: 17–27. (Erratum published 2021, Int. J. Womens Dermatol. 7: 867)

    Article  PubMed  Google Scholar 

  2. Erdmann, F., J. Lortet-Tieulent, J. Schüz, H. Zeeb, R. Greinert, E. W. Breitbart, and F. Bray (2013) International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? Int. J. Cancer 132: 385–400.

    Article  CAS  PubMed  Google Scholar 

  3. Naik, P. P. (2021) Cutaneous malignant melanoma: a review of early diagnosis and management. World J. Oncol. 12: 7–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Guy, G. P., Jr., S. R. Machlin, D. U. Ekwueme, and K. R. Yabroff (2015) Prevalence and costs of skin cancer treatment in the U.S., 2002–2006 and 2007–2011. Am. J. Prev. Med. 48: 183–187.

    Article  PubMed  Google Scholar 

  5. Sampogna, F., A. Paradisi, M. L. Iemboli, F. Ricci, G. Sonego, and D. Abeni (2019) Comparison of quality of life between melanoma and non-melanoma skin cancer patients. Eur. J. Dermatol. 29: 185–191.

    PubMed  Google Scholar 

  6. Miller, K. D., L. Nogueira, A. B. Mariotto, J. H. Rowland, K. R. Yabroff, C. M. Alfano, A. Jemal, J. L. Kramer, and R. L. Siegel (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69: 363–385.

    Article  PubMed  Google Scholar 

  7. Rios-Doria, J., N. Durham, L. Wetzel, R. Rothstein, J. Chesebrough, N. Holoweckyj, W. Zhao, C. C. Leow, and R. Hollingsworth (2015) Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models. Neoplasia 17: 661–670.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chitphet, K., S. M. Geary, C. H. Chan, A. L. Simons, G. J. Weiner, and A. K. Salem (2020) Combining doxorubicin-loaded PEGylated poly(lactide-co-glycolide) nanoparticles with checkpoint inhibition safely enhances therapeutic efficacy in a melanoma model. ACS Biomater. Sci. Eng. 6: 2659–2667.

    Article  CAS  PubMed  Google Scholar 

  9. Riley, R. S., C. H. June, R. Langer, and M. J. Mitchell (2019) Delivery technologies for cancer immunotherapy. Nat. Rev. Drug Discov. 18: 175–196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hershman, D. L., A. Eisenberger, J. Wang, J. Jacobson, V. Grann, R. McBride, W. Tsai, and A. Neugut (2007) Doxorubicin, cardiac risk factors and cardiac toxicity in elderly patients with diffuse b-cell non-Hodgkin’s lymphoma. J. Clin. Oncol. 25(18 Suppl): 9050.

    Article  Google Scholar 

  11. Renu, K., L. P. Pureti, B. Vellingiri, and A. Valsala Gopalakrishnan (2022) Toxic effects and molecular mechanism of doxorubicin on different organs — an update. Toxin Rev. 41: 650–674.

    Article  Google Scholar 

  12. Roberts, M. S., H. S. Cheruvu, S. E. Mangion, A. Alinaghi, H. A. Benson, Y. Mohammed, A. Holmes, J. van der Hoek, M. Pastore, and J. E. Grice (2021) Topical drug delivery: history, percutaneous absorption, and product development. Adv. Drug Deliv. Rev. 177: 113929.

    Article  CAS  PubMed  Google Scholar 

  13. Nagarkar, R., M. Singh, H. X. Nguyen, and S. Jonnalagadda (2020) A review of recent advances in microneedle technology for transdermal drug delivery. J. Drug Deliv. Sci. Technol. 59: 101923.

    Article  CAS  Google Scholar 

  14. Ye, Y., J. Yu, D. Wen, A. R. Kahkoska, and Z. Gu (2018) Polymeric microneedles for transdermal protein delivery. Adv. Drug Deliv. Rev. 127: 106–118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Jeon, E. Y., J. Lee, B. J. Kim, K. I. Joo, K. H. Kim, G. Lim, and H. J. Cha (2019) Bio-inspired swellable hydrogel-forming double-layered adhesive microneedle protein patch for regenerative internal/external surgical closure. Biomaterials 222: 119439.

    Article  CAS  PubMed  Google Scholar 

  16. Lim, S., T. Y. Park, E. Y. Jeon, K. I. Joo, and H. J. Cha (2021) Double-layered adhesive microneedle bandage based on biofunctionalized mussel protein for cardiac tissue regeneration. Biomaterials 278: 121171.

    Article  CAS  PubMed  Google Scholar 

  17. Waite, J. H. (1987) Nature’s underwater adhesive specialist. Int. J. Adhes. Adhes. 7: 9–14.

    Article  CAS  Google Scholar 

  18. Liu, C. (2022) Comparative proteomics for an in-depth understanding of bioadhesion mechanisms and evolution across metazoans. J. Proteomics 256: 104506.

    Article  CAS  PubMed  Google Scholar 

  19. Hwang, D. S., Y. Gim, H. J. Yoo, and H. J. Cha (2007) Practical recombinant hybrid mussel bioadhesive fp-151. Biomaterials 28: 3560–3568.

    Article  CAS  PubMed  Google Scholar 

  20. Choi, B.-H., H. Cheong, Y. K. Jo, S. Y. Bahn, J. H. Seo, and H. J. Cha (2014) Highly purified mussel adhesive protein to secure biosafety for in vivo applications. Microb. Cell Fact. 13: 52.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Jeon, E. Y., B. H. Hwang, Y. J. Yang, B. J. Kim, B.-H. Choi, G. Y. Jung, and H. J. Cha (2015) Rapidly light-activated surgical protein glue inspired by mussel adhesion and insect structural crosslinking. Biomaterials 67: 11–19.

    Article  CAS  PubMed  Google Scholar 

  22. Kim, B. J., D. X. Oh, S. Kim, J. H. Seo, D. S. Hwang, A. Masic, D. K. Han, and H. J. Cha (2014) Mussel-mimetic protein-based adhesive hydrogel. Biomacromolecules 15: 1579–1585.

    Article  CAS  PubMed  Google Scholar 

  23. Lim, S., Y. S. Choi, D. G. Kang, Y. H. Song, and H. J. Cha (2010) The adhesive properties of coacervated recombinant hybrid mussel adhesive proteins. Biomaterials 31: 3715–3722.

    Article  CAS  PubMed  Google Scholar 

  24. Jeong, Y., Y. K. Jo, B. J. Kim, B. Yang, K. I. Joo, and H. J. Cha (2018) Sprayable adhesive nanotherapeutics: mussel-protein-based nanoparticles for highly efficient locoregional cancer therapy. ACS Nano 12: 8909–8919.

    Article  CAS  PubMed  Google Scholar 

  25. Cheong, H., Y.-J. Jun, E. Y. Jeon, J. I. Lee, H. J. Jo, H. Y. Park, E. Kim, J. W. Rhie, K. I. Joo, and H. J. Cha (2022) Sutureless neurorrhaphy system using a macrophage-polarizing in situ visible light-crosslinkable adhesive protein hydrogel for functional nerve regeneration. Chem. Eng. J. 445: 136641.

    Article  CAS  Google Scholar 

  26. Wallin, R. F. and E. Arscott (1998) A practical guide to ISO 10993-5: cytotoxicity. Med. Device Diagn. Ind. 20: 96–98.

    Google Scholar 

  27. Park, J.-H., M. G. Allen, and M. R. Prausnitz (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J. Control. Release 104: 51–66.

    Article  CAS  PubMed  Google Scholar 

  28. Ranamukhaarachchi, S. A., S. Lehnert, S. L. Ranamukhaarachchi, L. Sprenger, T. Schneider, I. Mansoor, K. Rai, U. Häfeli, and B. Stoeber (2016) A micromechanical comparison of human and porcine skin before and after preservation by freezing for medical device development. Sci. Rep. 6: 32074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lu, Q., E. Danner, J. H. Waite, J. N. Israelachvili, H. Zeng, and D. S. Hwang (2013) Adhesion of mussel foot proteins to different substrate surfaces. J. R. Soc. Interface 10: 20120759.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kim, S., A. Faghihnejad, Y. Lee, Y. Jho, H. Zeng, and D. S. Hwang (2015) Cation-π interaction in DOPA-deficient mussel adhesive protein mfp-1. J. Mater. Chem. B 3: 738–743.

    Article  CAS  PubMed  Google Scholar 

  31. Hwang, D. S., H. Zeng, Q. Lu, J. Israelachvili, and J. H. Waite (2012) Adhesion mechanism in a DOPA-deficient foot protein from green mussels. Soft Matter 8: 5640–5648.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Tacar, O., P. Sriamornsak, and C. R. Dass (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol. 65: 157–170.

    Article  CAS  PubMed  Google Scholar 

  33. Thedrattanawong, C., C. Manaspon, and N. Nasongkla (2018) Controlling the burst release of doxorubicin from polymeric depots via adjusting hydrophobic/hydrophilic properties. J. Drug Deliv. Sci. Technol. 46: 446–451.

    Article  CAS  Google Scholar 

  34. Senapati, S., A. K. Mahanta, S. Kumar, and P. Maiti (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct. Target. Ther. 3: 7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Li, J. and D. J. Mooney (2016) Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 1: 16071.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. de Moura, L. D., L. N. M. Ribeiro, F. V. de Carvalho, G. H. Rodrigues da Silva, P. C. Lima Fernandes, S. Q. Brunetto, C. D. Ramos, L. A. Velloso, D. R. de Araújo, and E. de Paula (2021) Docetaxel and lidocaine co-loaded (NLC-in-hydrogel) hybrid system designed for the treatment of melanoma. Pharmaceutics 13: 1552.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Debreli Coskun, M., T. Sudha, D. J. Bharali, S. Celikler, P. J. Davis, and S. A. Mousa (2020) αvβ3 integrin antagonists enhance chemotherapy response in an orthotopic pancreatic cancer model. Front. Pharmacol. 11: 95.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Alyahya, R., T. Sudha, M. Racz, S. C. Stain, and S. A. Mousa (2015) Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models. Int. J. Oncol. 46: 1225–1231.

    Article  CAS  PubMed  Google Scholar 

  39. Vargason, A. M., A. C. Anselmo, and S. Mitragotri (2021) The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 5: 951–967.

    Article  PubMed  Google Scholar 

  40. Li, L., R. Chen, D. Zhou, J. Sun, L. Wang, L. Zhu, H. Shen, W. Xie, and X. Ye (2022) The efficacy and cardiac toxicity of different-dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma. Cancer Med. Advance online publication. doi: https://doi.org/10.1002/cam4.5280

  41. Barenholz, Y. C. (2012) Doxil®—the first FDA-approved nanodrug: lessons learned. J. Control. Release 160: 117–134.

    Article  CAS  PubMed  Google Scholar 

  42. Kim, H. J., B. Yang, T. Y. Park, S. Lim, and H. J. Cha (2017) Complex coacervates based on recombinant mussel adhesive proteins: their characterization and applications. Soft Matter 13: 7704–7716.

    Article  CAS  PubMed  Google Scholar 

  43. Park, T. Y., J.-M. Oh, J. S. Cho, S. B. Sim, J. Lee, and H. J. Cha (2020) Stem cell-loaded adhesive immiscible liquid for regeneration of myocardial infarction. J. Control. Release 321: 602–615.

    Article  CAS  PubMed  Google Scholar 

  44. Park, T. Y., E. Y. Jeon, H. J. Kim, B.-H. Choi, and H. J. Cha (2019) Prolonged cell persistence with enhanced multipotency and rapid angiogenesis of hypoxia pre-conditioned stem cells encapsulated in marine-inspired adhesive and immiscible liquid micro-droplets. Acta Biomater. 86: 257–268.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the financial support by the High Value-added Food Technology Development Program (grant number: 321025051HD060) through the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET), funded by the Ministry of Agriculture, Food & Rural Affairs, Republic of Korea.

Author information

Author notes

  1. Eun Young Jeon

    Present address: Present address: Department of Dermatology, Columbia University Irving Medical Center, New York, NY, 10032, USA

  2. Junghwan Heo and Eun Young Jeon contributed equally to this work.

Authors and Affiliations

  1. Department of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, Korea

    Junghwan Heo, Eun Young Jeon & Hyung Joon Cha

  2. Division of Chemical Engineering and Materials Science, Ewha Womans University, Seoul, 03760, Korea

    Kye Il Joo

Authors
  1. Junghwan Heo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eun Young Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kye Il Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyung Joon Cha
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J. Heo: Conceptualization, Validation, Investigation, Writing. E.Y. Jeon: Validation, Methodology, Visualization, Writing. K.I. Joo: Conceptualization, Validation. H.J. Cha: Supervision, Funding acquisition, Resources, Writing.

Corresponding author

Correspondence to Hyung Joon Cha.

Ethics declarations

The authors declare no competing financial interests or personal relationships. All animal studies were conducted according to guidelines of national regulations and the approval of the local Institutional Animal Care and Use Committee (POSTECH-2018-0009).

Additional information

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heo, J., Jeon, E.Y., Joo, K.I. et al. Locoregional Melanoma Therapy by Tissue Adhesive Microneedle Patch-assisted Trans-tumoral Delivery of Anticancer Drug. Biotechnol Bioproc E 28, 473–482 (2023). https://doi.org/10.1007/s12257-022-0299-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12257-022-0299-y

Keywords

Search

Navigation